Healthy volunteers help compare edaravone delivery methods
NCT ID NCT04776135
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study looked at how the drug edaravone enters the body when given as a liquid by mouth or through a nasogastric tube (a thin tube that goes through the nose to the stomach). It involved 36 healthy Japanese adults aged 20 to 45. The main goal was to measure drug levels in the blood to see if both methods work similarly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Investigational site
Tokyo, Toshima-ku, 171-0014, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill help regulate blood sugar? early trial puts PSTC100 to the test
- First human trial launches for experimental PSTB100 drug
- Syringe showdown: does a prefilled device deliver drug as well as a vial?
- Healthy volunteers help unlock the Body's handling of a new drug
- New edaravone tablet tested in healthy volunteers
- Healthy volunteers test new Drug's body processing